Date	Events	Pharmacological treatment	Non-pharmacological treatment	Lifestyle advice	Body weight (kg)	Blood pressure (mmHg)	Heart rate (bpm)	Rhythm	B-type natriuretic peptide (pg/mL)	Left ventricular end-diastolic diameter (mm)	Left ventricular ejection fraction (%)
February, 2012	Heart failure hospitalization (HFH), 1st	Carvedilol	Cardiac rehabilitation (CR)	Usual self-care education (USCE)				Normal sinus rhythm (NSR)	1150	70	24
	Diagnosed with dilated cardiomyopathy	Spironolactone			68.9	98/60	100	NSR
		Enalapril			60.5	90/60	75	NSR
June, 2014				USCE	59.5	120/70	80	NSR	36
January, 2018	HFH, 2nd, on admission		CR	USCE	59.8	96/75	106	NSR	946	73	18
	on discharge				54.3	83/53	83	NSR	262
May, 2018	HFH, 3rd, on admission	Pimobendan	CR	USCE	59.6	93/67	95	NSR	1734	74	13
	on discharge				53.5	80/50	75	NSR	287
August, 2018	HFH, 4th, on admission		CR	USCE	61.5	97/50	110	NSR	1211	79	22
	on discharge				55.3	79/48	78	NSR	432
September, 2018	HFH, 5th, on admission		CR	USCE	59.8	90/70	112	NSR	1666
	on discharge				55.5	92/55	84	NSR	288
July, 2019	HFH, 6th, on admission		CR	USCE	59.8	88/67	109	NSR	1767	75	15
	on discharge				56.8	99/69	85	NSR	573
August, 2019	HFH, 7th, on admission		CR	USCE	58.5	91/67	101	NSR	1628	74	15
	on discharge				56.5	89/63	82	NSR	405
September, 2019	HFH, 8th, on admission		CR, cardiac resynchronization therapy	USCE	58.9	85/58	93	NSR	1859	80	22
	on discharge				56.0	97/67	91	NSR	257
December, 2019	HFH, 9th, on admission		CR	Motivational Interviewing	61.0	85/53	114	NSR	988	78	18
	on discharge		CR		57.0	90/60	92	NSR	202
March, 2021	15 months after hospital discharge				62.0	112/78	72	NSR	19	64	37